TRIM32 is a proliferation and anti-apoptotic factor that participates in the AKT pathway of gastric cancer cells and promotes cell growth by enhancing the activity of AKT and glucose transport (Wang et al., 2020). This evidence concerns the gene AKT1 and gastric cancer.